- Home
- TVGN vs DMA Comparison
TVGN vs DMA Comparison
Compare TVGN & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Company Overview
Basic Information| Metric | TVGN | DMA |
|---|---|---|
| Founded | 2020 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.6M | 78.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TVGN | DMA |
|---|---|---|
| Price | $0.40 | $9.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 34.6K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.38 | $4.78 |
| 52 Week High | $1.92 | $8.00 |
Technical Indicators
Market Signals| Indicator | TVGN | DMA |
|---|---|---|
| Relative Strength Index (RSI) | 40.91 | 72.77 |
| Support Level | $0.39 | $8.63 |
| Resistance Level | $0.47 | $8.79 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 20.37 | 92.73 |
Price Performance
Historical Comparison TVGN
DMA
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.